
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity
Sascha Baumann, Jennifer Herrmann, Ritesh Raju, et al.
Angewandte Chemie International Edition (2014) Vol. 53, Iss. 52, pp. 14605-14609
Closed Access | Times Cited: 160
Sascha Baumann, Jennifer Herrmann, Ritesh Raju, et al.
Angewandte Chemie International Edition (2014) Vol. 53, Iss. 52, pp. 14605-14609
Closed Access | Times Cited: 160
Showing 1-25 of 160 citing articles:
Evolutionary Rationale for Phages as Complements of Antibiotics
Clara Torres-Barceló, Michael Hochberg
Trends in Microbiology (2016) Vol. 24, Iss. 4, pp. 249-256
Closed Access | Times Cited: 269
Clara Torres-Barceló, Michael Hochberg
Trends in Microbiology (2016) Vol. 24, Iss. 4, pp. 249-256
Closed Access | Times Cited: 269
Natural Products as a Source for Novel Antibiotics
Mark G. Moloney
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 8, pp. 689-701
Open Access | Times Cited: 261
Mark G. Moloney
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 8, pp. 689-701
Open Access | Times Cited: 261
Novel Strategies for the Treatment ofPseudomonas aeruginosaInfections
Stefanie Wagner, Roman Sommer, Stefan Hinsberger, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 13, pp. 5929-5969
Closed Access | Times Cited: 235
Stefanie Wagner, Roman Sommer, Stefan Hinsberger, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 13, pp. 5929-5969
Closed Access | Times Cited: 235
History of Antibiotics Research
Kathrin I. Mohr
Current topics in microbiology and immunology (2016), pp. 237-272
Closed Access | Times Cited: 233
Kathrin I. Mohr
Current topics in microbiology and immunology (2016), pp. 237-272
Closed Access | Times Cited: 233
Natural products from myxobacteria: novel metabolites and bioactivities
Jennifer Herrmann, Antoine Abou Fayad, Rolf Müller
Natural Product Reports (2016) Vol. 34, Iss. 2, pp. 135-160
Closed Access | Times Cited: 224
Jennifer Herrmann, Antoine Abou Fayad, Rolf Müller
Natural Product Reports (2016) Vol. 34, Iss. 2, pp. 135-160
Closed Access | Times Cited: 224
The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial Agents
Christian Hobson, Andrew N. Chan, Gerard D. Wright
Chemical Reviews (2021) Vol. 121, Iss. 6, pp. 3464-3494
Closed Access | Times Cited: 164
Christian Hobson, Andrew N. Chan, Gerard D. Wright
Chemical Reviews (2021) Vol. 121, Iss. 6, pp. 3464-3494
Closed Access | Times Cited: 164
ARTS 2.0: feature updates and expansion of the Antibiotic Resistant Target Seeker for comparative genome mining
Mehmet Direnç Mungan, Mohammad Alanjary, Kai Blin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. W1, pp. W546-W552
Open Access | Times Cited: 155
Mehmet Direnç Mungan, Mohammad Alanjary, Kai Blin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. W1, pp. W546-W552
Open Access | Times Cited: 155
Genome mining methods to discover bioactive natural products
Katherine D. Bauman, Keelie S. Butler, Bradley S. Moore, et al.
Natural Product Reports (2021) Vol. 38, Iss. 11, pp. 2100-2129
Open Access | Times Cited: 118
Katherine D. Bauman, Keelie S. Butler, Bradley S. Moore, et al.
Natural Product Reports (2021) Vol. 38, Iss. 11, pp. 2100-2129
Open Access | Times Cited: 118
Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, et al.
EMBO Reports (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 114
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, et al.
EMBO Reports (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 114
Strategies to access biosynthetic novelty in bacterial genomes for drug discovery
Franziska Hemmerling, Jörn Piel
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 5, pp. 359-378
Closed Access | Times Cited: 87
Franziska Hemmerling, Jörn Piel
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 5, pp. 359-378
Closed Access | Times Cited: 87
Insights into the chemical logic and enzymatic machinery of NRPS assembly lines
Christopher T. Walsh
Natural Product Reports (2015) Vol. 33, Iss. 2, pp. 127-135
Closed Access | Times Cited: 167
Christopher T. Walsh
Natural Product Reports (2015) Vol. 33, Iss. 2, pp. 127-135
Closed Access | Times Cited: 167
Thinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis
Markus Lakemeyer, Weining Zhao, Franziska A. Mandl, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 44, pp. 14440-14475
Closed Access | Times Cited: 156
Markus Lakemeyer, Weining Zhao, Franziska A. Mandl, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 44, pp. 14440-14475
Closed Access | Times Cited: 156
Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights
Joleen Masschelein, Matthew Jenner, Gregory L. Challis
Natural Product Reports (2017) Vol. 34, Iss. 7, pp. 712-783
Closed Access | Times Cited: 105
Joleen Masschelein, Matthew Jenner, Gregory L. Challis
Natural Product Reports (2017) Vol. 34, Iss. 7, pp. 712-783
Closed Access | Times Cited: 105
Biocompatible bacteria-derived vesicles show inherent antimicrobial activity
Eilien Schulz, Adriely Goes, Ronald Garcia, et al.
Journal of Controlled Release (2018) Vol. 290, pp. 46-55
Open Access | Times Cited: 100
Eilien Schulz, Adriely Goes, Ronald Garcia, et al.
Journal of Controlled Release (2018) Vol. 290, pp. 46-55
Open Access | Times Cited: 100
Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria
Fabian Panter, Daniel Krug, Sascha Baumann, et al.
Chemical Science (2018) Vol. 9, Iss. 21, pp. 4898-4908
Open Access | Times Cited: 99
Fabian Panter, Daniel Krug, Sascha Baumann, et al.
Chemical Science (2018) Vol. 9, Iss. 21, pp. 4898-4908
Open Access | Times Cited: 99
Recent advances in DNA gyrase-targeted antimicrobial agents
Satish N. Dighe, Trudi Collet
European Journal of Medicinal Chemistry (2020) Vol. 199, pp. 112326-112326
Closed Access | Times Cited: 98
Satish N. Dighe, Trudi Collet
European Journal of Medicinal Chemistry (2020) Vol. 199, pp. 112326-112326
Closed Access | Times Cited: 98
Diversity of Myxobacteria—We Only See the Tip of the Iceberg
Kathrin I. Mohr
Microorganisms (2018) Vol. 6, Iss. 3, pp. 84-84
Open Access | Times Cited: 97
Kathrin I. Mohr
Microorganisms (2018) Vol. 6, Iss. 3, pp. 84-84
Open Access | Times Cited: 97
Assembly and clustering of natural antibiotics guides target identification
Chad W. Johnston, Michael A. Skinnider, Chris A. Dejong, et al.
Nature Chemical Biology (2016) Vol. 12, Iss. 4, pp. 233-239
Closed Access | Times Cited: 96
Chad W. Johnston, Michael A. Skinnider, Chris A. Dejong, et al.
Nature Chemical Biology (2016) Vol. 12, Iss. 4, pp. 233-239
Closed Access | Times Cited: 96
In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites
Chantal D. Bader, Fabian Panter, Rolf Müller
Biotechnology Advances (2019) Vol. 39, pp. 107480-107480
Closed Access | Times Cited: 77
Chantal D. Bader, Fabian Panter, Rolf Müller
Biotechnology Advances (2019) Vol. 39, pp. 107480-107480
Closed Access | Times Cited: 77
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering
Sebastian Groß, Fabian Panter, Domen Pogorevc, et al.
Chemical Science (2021) Vol. 12, Iss. 35, pp. 11882-11893
Open Access | Times Cited: 62
Sebastian Groß, Fabian Panter, Domen Pogorevc, et al.
Chemical Science (2021) Vol. 12, Iss. 35, pp. 11882-11893
Open Access | Times Cited: 62
Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidin
Elizabeth Michalczyk, Kay Hommernick, Iraj Behroz, et al.
Nature Catalysis (2023) Vol. 6, Iss. 1, pp. 52-67
Open Access | Times Cited: 29
Elizabeth Michalczyk, Kay Hommernick, Iraj Behroz, et al.
Nature Catalysis (2023) Vol. 6, Iss. 1, pp. 52-67
Open Access | Times Cited: 29
Antibiotics from predatory bacteria
Juliane Korp, María Soledad Vela Gurovic, Markus Nett
Beilstein Journal of Organic Chemistry (2016) Vol. 12, pp. 594-607
Open Access | Times Cited: 77
Juliane Korp, María Soledad Vela Gurovic, Markus Nett
Beilstein Journal of Organic Chemistry (2016) Vol. 12, pp. 594-607
Open Access | Times Cited: 77
Self-Resistance of Natural Product Producers: Past, Present, and Future Focusing on Self-Resistant Protein Variants
Khaled H. Almabruk, Linh K. Dinh, Benjamin Philmus
ACS Chemical Biology (2018) Vol. 13, Iss. 6, pp. 1426-1437
Closed Access | Times Cited: 76
Khaled H. Almabruk, Linh K. Dinh, Benjamin Philmus
ACS Chemical Biology (2018) Vol. 13, Iss. 6, pp. 1426-1437
Closed Access | Times Cited: 76
Actinobacteria and Myxobacteria—Two of the Most Important Bacterial Resources for Novel Antibiotics
Wiebke Landwehr, Corinna Wolf, Joachim Wink
Current topics in microbiology and immunology (2016), pp. 273-302
Open Access | Times Cited: 69
Wiebke Landwehr, Corinna Wolf, Joachim Wink
Current topics in microbiology and immunology (2016), pp. 273-302
Open Access | Times Cited: 69
Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram‐Negative Pathogens
Stephan Hüttel, Giambattista Testolin, Jennifer Herrmann, et al.
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 41, pp. 12760-12764
Closed Access | Times Cited: 68
Stephan Hüttel, Giambattista Testolin, Jennifer Herrmann, et al.
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 41, pp. 12760-12764
Closed Access | Times Cited: 68